Lessons from Global Health, Tadataka Yamada, MD
The Early Translational Research Program of UCSF's Clinical and Translational Science Institue (CTSI)
Friday, February 8, 2013 from 10:00 AM to 11:00 AM (PST)
San Francisco, California
London, United Kingdom
In his current role at Takeda Pharmaceuticals, Dr. Tadataka (Tachi) Yamada is responsible for all of Takeda’s research and development activities. He chairs the Corporate Management Operating Committee that oversees all investments in research and development, business development and in-licensing. Previously, as President of the Bill and Melinda Gates Foundation Global Health Program, Dr. Yamada oversaw grants totaling $9 billion in programs directed at applying technologies to address major health challenges of the developing world. Dr. Yamada’s previous roles have included Chairman, Research and Development and a Member of the Board of Directors of GlaxoSmithKline; and Chairman, Department of Internal Medicine and Physician-in-Chief of the University of Michigan Medical Center.